Secondary glaucoma after intravitreal dexamethasone implant in the patient with macular edema secondary to retinitis pigmentosa

Macular edema can be occured in cases of retinitis pigmentosa. One of the treatment agent for cystoid macular edema secondary to retinitis pigmentosa is intravitreal Ozurdex implant. Secondary glaucoma is one of the complication of intravitreal corticosteroid injection for macular edema. In this article the retinitis pigmantosa case with secondary glaucoma resistent to medical treatment after ozurdex implant for refractory macular edema is presented. To present a case with bilateral refractory macular edema secondary to retinitis pigmentosa improved glaucoma in one eye after one month following Ozurdex® (Allergan, Inc., Irvine, CA, USA) implantation. Further studies are needed to confi rm the safety and effi cacy of intravitreal Ozurdex® for macular edema in retinitis pigmentosa.